A detailed history of Orbimed Advisors LLC transactions in Elevance Health, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 106,200 shares of ELV stock, worth $42.6 Million. This represents 1.3% of its overall portfolio holdings.

Number of Shares
106,200
Previous 168,100 36.82%
Holding current value
$42.6 Million
Previous $91.1 Million 39.37%
% of portfolio
1.3%
Previous 2.2%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$500.12 - $562.29 $31 Million - $34.8 Million
-61,900 Reduced 36.82%
106,200 $55.2 Million
Q1 2024

May 15, 2024

BUY
$464.61 - $519.96 $12.4 Million - $13.8 Million
26,600 Added 18.8%
168,100 $87.2 Million
Q4 2023

Feb 14, 2024

BUY
$433.51 - $488.06 $61.3 Million - $69.1 Million
141,500 New
141,500 $66.7 Million
Q4 2021

Feb 14, 2022

SELL
$370.08 - $467.67 $76.6 Million - $96.9 Million
-207,100 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$357.51 - $398.13 $46 Million - $51.2 Million
-128,600 Reduced 38.31%
207,100 $77.2 Million
Q2 2021

Aug 16, 2021

BUY
$352.19 - $401.9 $17.3 Million - $19.7 Million
49,100 Added 17.13%
335,700 $128 Million
Q1 2021

May 17, 2021

SELL
$287.7 - $371.31 $6.88 Million - $8.87 Million
-23,900 Reduced 7.7%
286,600 $103 Million
Q4 2020

Feb 16, 2021

BUY
$270.17 - $333.15 $83.9 Million - $103 Million
310,500 New
310,500 $99.7 Million
Q1 2020

May 15, 2020

SELL
$174.68 - $307.74 $18.6 Million - $32.8 Million
-106,600 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$234.82 - $306.42 $34.8 Million - $45.4 Million
-148,000 Reduced 58.13%
106,600 $32.2 Million
Q3 2019

Nov 14, 2019

SELL
$237.69 - $310.48 $25.4 Million - $33.2 Million
-107,000 Reduced 29.59%
254,600 $61.1 Million
Q2 2019

Aug 14, 2019

BUY
$236.25 - $293.76 $8.6 Million - $10.7 Million
36,400 Added 11.19%
361,600 $102 Million
Q1 2019

May 15, 2019

BUY
$248.42 - $317.42 $4.92 Million - $6.28 Million
19,800 Added 6.48%
325,200 $93.3 Million
Q4 2018

Feb 14, 2019

SELL
$249.0 - $296.25 $42 Million - $49.9 Million
-168,600 Reduced 35.57%
305,400 $80.2 Million
Q3 2018

Nov 14, 2018

SELL
$238.27 - $274.12 $13.8 Million - $15.8 Million
-57,800 Reduced 10.87%
474,000 $130 Million
Q2 2018

Aug 14, 2018

BUY
$220.13 - $245.16 $117 Million - $130 Million
531,800 New
531,800 $127 Million
Q1 2018

May 15, 2018

SELL
$215.63 - $258.19 $142 Million - $170 Million
-658,718 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$183.76 - $234.96 $49.4 Million - $63.2 Million
-268,900 Reduced 28.99%
658,718 $148 Million
Q3 2017

Nov 14, 2017

BUY
$181.44 - $197.43 $168 Million - $183 Million
927,618
927,618 $176 Million

Others Institutions Holding ELV

About Elevance Health, Inc.


  • Ticker ELV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 240,000,992
  • Market Cap $96.2B
  • Description
  • Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....
More about ELV
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.